Quantcast
Last updated on April 17, 2014 at 17:30 EDT

Latest infectious disease Stories

2014-04-09 23:04:46

According to the Centers for Disease Control and Prevention (CDC), there is an urgent need for all healthcare providers to engage in antimicrobial stewardship to manage the appropriate use of antimicrobials. Leaders will need to direct and supervise stewardship plans and will need training to achieve optimal clinical patient outcomes related to antimicrobial use. Bethesda, Maryland (PRWEB) April 09, 2014 The National Foundation for Infectious Diseases (NFID) is partnering with Making a...

2014-03-31 10:02:20

Stigmatization may have once served to protect early humans from infectious diseases, but that strategy may do more harm than good for modern humans, according to Penn State researchers. "The things that made stigmas a more functional strategy thousands of years ago rarely exist," said Rachel Smith, associate professor of communication arts and sciences and human development and family studies. "Now, it won't promote positive health behavior and, in many cases, it could actually make the...

2014-03-25 08:29:52

Resistance to current drugs spurs treatment innovation in influenza, respiratory syncytial virus, chlamydia and gonorrhoea LONDON, March 25, 2014 /PRNewswire/ -- The available antivirals for commonly occurring infections such as respiratory syncytial virus (RSV) and influenza are characterised by variable response, poor tolerability and suboptimal dosing regimens, limiting their regular use and efficacy. Likewise, the development of resistance to almost every recommended antibiotic...

2014-03-11 16:23:18

LONDON, March 11, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:Lateral Flow Technology And The Future Of Point Of Care Diagnostics, 2nd Edition Lateral flow (LF) tests, also known as immunochromatographic strip (ICS) tests, are point of care tests that reduce the time spent waiting for test results from hours to minutes, require less training for operators, and reduce the cost of both device development and care. This report, Lateral Flow...

2014-03-10 12:25:52

PINE BROOK, N.J., March 10, 2014 /PRNewswire/ -- Elusys Therapeutics, Inc. (Elusys), a biopharmaceutical company developing antibody therapies to treat infectious disease, announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. Application Serial Number 13/076,082, granting a patent which covers methods of preventing or treating anthrax with ETI-204, the company's anti-anthrax antibody, together with antibiotics. The patent also...

2014-02-26 08:29:00

SAN DIEGO, Feb. 26, 2014 /PRNewswire/ -- Aethlon Medical, Inc. (OTCQX:AEMD), the pioneer in developing selective therapeutic filtration devices to address infectious disease, cancer and other life-threatening conditions, announced today that that it has reached an agreement in principle with DaVita Clinical Research® (DCR) to provide clinical management services that will support forthcoming studies of the Aethlon Hemopurifier®. The Hemopurifier® is a first-in-class therapeutic...

2014-02-07 13:09:09

Production of an exceptionally large surface protein prevents bacteria from forming clumps and reduces their ability to cause disease A genetic mechanism that controls the production of a large spike-like protein on the surface of Staphylococcus aureus (staph) bacteria alters the ability of the bacteria to form clumps and to cause disease, according to a new University of Iowa study. The new study is the first to link this genetic mechanism to the production of the giant surface protein...

2014-02-05 12:28:03

Over 400 subjects participating in phase 3 studies PINE BROOK, N.J., Feb. 5, 2014 /PRNewswire/ -- Elusys Therapeutics, Inc. (Elusys), a biopharmaceutical company developing antibody therapies to treat infectious disease, today announced it has completed enrollment in three phase 3 safety studies of ETI-204, an anti-toxin in development for the treatment of inhalational anthrax. Elusys also announced it has completed enrollment in an additional study to evaluate the tolerability...

Pathogen Responsible For Two Historical Plagues Could Reemerge
2014-01-28 10:26:57

[ Watch the Video: Pathogen Behind Ancient Plagues Could Come Back Someday ] Brett Smith for redOrbit.com - Your Universe Online Both the Plague of Justinian in 541 and Black Death some 800 years later were responsible for widespread fatalities across Europe. Now, new research in The Lancet Infectious Diseases journal has found that both pandemics were caused by different strains of the same pathogen. The international team of study authors also concluded that a new strain of plague...

2014-01-22 23:05:08

Immunoassays conducted for the purpose of determining the presence of infectious disease in a patient lead the market for this important IVD test, both in size of market and in the rate of revenue growth, according to “The World Market for Immunoassays,” a recent study by Kalorama Information. New York, NY (PRWEB) January 22, 2014 Immunoassays conducted for the purpose of determining the presence of infectious disease in a patient lead the market for this important IVD test, both in...


Latest infectious disease Reference Libraries

69_3e2a06a821d939ffdc2eab851bee21e9
2011-01-24 12:50:52

Hepatitis A, caused by hepatitis A virus, is an acute infectious disease of the liver that is transmitted person to person by ingestion of contaminated food or water or through direct contact with an infectious person. Millions of people are believed to become infected with HAV every year. The incubation period is two to six weeks and on average is 28 days. In less developed countries the HAV is usually contracted in early childhood. Clean water helps to decrease contraction of HAV. In 90%...

More Articles (1 articles) »